EG24161A - Carbostyril derivatives - Google Patents

Carbostyril derivatives

Info

Publication number
EG24161A
EG24161A EG94298A EG94298A EG24161A EG 24161 A EG24161 A EG 24161A EG 94298 A EG94298 A EG 94298A EG 94298 A EG94298 A EG 94298A EG 24161 A EG24161 A EG 24161A
Authority
EG
Egypt
Prior art keywords
carbostyril derivatives
carbostyril
derivatives
Prior art date
Application number
EG94298A
Other languages
English (en)
Inventor
Yasuo Oshiro
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of EG24161A publication Critical patent/EG24161A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
EG94298A 1997-08-19 1998-08-13 Carbostyril derivatives EG24161A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22243197 1997-08-19

Publications (1)

Publication Number Publication Date
EG24161A true EG24161A (en) 2008-08-20

Family

ID=16782296

Family Applications (1)

Application Number Title Priority Date Filing Date
EG94298A EG24161A (en) 1997-08-19 1998-08-13 Carbostyril derivatives

Country Status (20)

Country Link
US (1) US6133264A (xx)
EP (1) EP1005458B1 (xx)
JP (1) JPH11124366A (xx)
KR (1) KR100397201B1 (xx)
CN (1) CN1141298C (xx)
AR (1) AR013945A1 (xx)
AT (1) ATE279395T1 (xx)
AU (1) AU725464B2 (xx)
BR (1) BR9811307A (xx)
CA (1) CA2297439C (xx)
DE (1) DE69827014T2 (xx)
DK (1) DK1005458T3 (xx)
EG (1) EG24161A (xx)
ES (1) ES2232001T3 (xx)
HK (1) HK1029346A1 (xx)
ID (1) ID23521A (xx)
MY (1) MY115907A (xx)
PT (1) PT1005458E (xx)
TW (1) TW436483B (xx)
WO (1) WO1999009011A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020034772A1 (en) 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
US20020114769A1 (en) * 2000-09-14 2002-08-22 Rotenberg Susan A. Novel dequalinium analogs
WO2011094016A1 (en) 2010-01-28 2011-08-04 New York University Compounds, compositions and methods for preventing skin darkening
US8772252B2 (en) 2011-01-27 2014-07-08 New York University Coumarin compounds as melanogenesis modifiers and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1219587A (en) * 1981-12-14 1987-03-24 Norman P. Jensen Hydroxybenzylaminobenzenes as anti-inflammatory agents
US5082847A (en) * 1990-07-18 1992-01-21 Syntex (U.S.A.) Inc. Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
CA2134448A1 (en) * 1992-05-01 1993-11-02 Yoshinori Kyotani Quinoline derivative or salt thereof and remedy for cardiac diseases containing the same
TW448161B (en) * 1994-07-14 2001-08-01 Otsuka Pharma Co Ltd Cyclic amide derivatives
ES2155601T3 (es) * 1995-07-07 2001-05-16 Pfizer Compuestos de benzolactama sustituidos como antagonistas de la sustancia p.
EP0918522A4 (en) * 1996-05-20 1999-08-18 Merck & Co Inc GONADOTROPIN RELEASING HORMONE ANTAGONISTS
JP2000511533A (ja) * 1996-05-20 2000-09-05 メルク エンド カンパニー インコーポレーテッド ゴナドトロピン放出ホルモン拮抗薬

Also Published As

Publication number Publication date
EP1005458B1 (en) 2004-10-13
PT1005458E (pt) 2005-01-31
HK1029346A1 (en) 2001-03-30
EP1005458A1 (en) 2000-06-07
MY115907A (en) 2003-09-30
CA2297439C (en) 2006-12-19
CN1141298C (zh) 2004-03-10
AU725464B2 (en) 2000-10-12
CA2297439A1 (en) 1999-02-25
BR9811307A (pt) 2000-08-29
ID23521A (id) 2000-04-27
DE69827014D1 (de) 2004-11-18
AR013945A1 (es) 2001-01-31
CN1267284A (zh) 2000-09-20
DE69827014T2 (de) 2005-03-17
WO1999009011A1 (en) 1999-02-25
TW436483B (en) 2001-05-28
AU8650098A (en) 1999-03-08
ATE279395T1 (de) 2004-10-15
KR100397201B1 (ko) 2003-09-13
US6133264A (en) 2000-10-17
DK1005458T3 (da) 2005-01-31
ES2232001T3 (es) 2005-05-16
JPH11124366A (ja) 1999-05-11
KR20010023086A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
IL143782A0 (en) Quinoline derivatives
PL343420A1 (en) Quinoline derivatives
PL345388A1 (en) Quinoline derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
PL345389A1 (en) Quinoline derivatives
GB9809664D0 (en) a-Ketoamide derivatives
HU9801168D0 (en) Triazinylaminostilbene derivatives
ZA977326B (en) Tetrahydroquinoline derivatives
EG23802A (en) 2-Phenylpyran-4-one derivatives
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
EG24161A (en) Carbostyril derivatives
ZA983116B (en) Arylsecocholadiene derivatives
EP1061912A4 (en) PHENANTHROFURANDERIVATE
HU9800889D0 (en) New naphtylpiperazine derivatives
IL131159A0 (en) 4-Aminoethoxyindazole derivatives
GB9706753D0 (en) Aralkoxy-morphinan derivatives
SI1005445T1 (en) N-alkanoylphenylalanine derivatives